TAO Pumping, BTC/ETH/Gold/Silver Up is the Worst Over? #CryptoTownHall

This episode dissects crypto market chaos, argues Bitcoin’s asymmetric upside, and explains a dual‑engine treasury using prediction‑market tokens to self‑fund biotech clinical programs.

Key Takeaways

Market: Bitcoin endures amid unprecedented volatility; sellers look exhausted—view sharp dips as buying opportunities while using simple buy‑and‑hold and opportunistic rebalancing tactics.
Manage risk: avoid overleveraging, preserve sleep, size positions and accept doing nothing when appropriate—practical advice beats big, uncertain return promises.
Token realism: most tokens lack real value capture; expect many meme/NFT assets to go to zero—demand audits, on‑chain metrics, and avoid tribal narratives before allocating capital.
Dual‑engine treasury: biotech company pairs a RAIN‑token treasury with clinical operations, completed a discounted PIPE to acquire RAIN, and uses yield to self‑fund trials.
Milestones to watch: FDA Phase 2b start and expected meaningful 2027 data; monitor RAIN adoption, treasury yield growth, and clinical progress as key inflection points.
Macro view: if total crypto market cap expands tenfold, Bitcoin dominance implies far higher BTC prices; favor established chains (BTC, ETH, SOL) for lower‑risk exposure.

Original Source

Visit Source